GB201703272D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB201703272D0
GB201703272D0 GBGB1703272.3A GB201703272A GB201703272D0 GB 201703272 D0 GB201703272 D0 GB 201703272D0 GB 201703272 A GB201703272 A GB 201703272A GB 201703272 D0 GB201703272 D0 GB 201703272D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1703272.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Intellectual Property Development Ltd
Original Assignee
GlaxoSmithKline Intellectual Property Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Intellectual Property Development Ltd filed Critical GlaxoSmithKline Intellectual Property Development Ltd
Priority to GBGB1703272.3A priority Critical patent/GB201703272D0/en
Priority to PCT/EP2017/058049 priority patent/WO2017174620A1/en
Priority to KR1020187029128A priority patent/KR20180132680A/en
Priority to EP17715714.6A priority patent/EP3440075B1/en
Priority to RU2018133500A priority patent/RU2018133500A/en
Priority to JP2018552148A priority patent/JP6954920B2/en
Priority to CN201780020627.5A priority patent/CN108884083B/en
Priority to CA3018275A priority patent/CA3018275A1/en
Priority to ES17715714T priority patent/ES2785173T3/en
Priority to US16/091,577 priority patent/US10583112B2/en
Priority to BR112018070514A priority patent/BR112018070514A2/en
Priority to UY0001037191A priority patent/UY37191A/en
Priority to TW106111350A priority patent/TW201802076A/en
Priority to AU2017245640A priority patent/AU2017245640A1/en
Publication of GB201703272D0 publication Critical patent/GB201703272D0/en
Ceased legal-status Critical Current

Links

GBGB1703272.3A 2016-04-07 2017-03-01 Compounds Ceased GB201703272D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB1703272.3A GB201703272D0 (en) 2017-03-01 2017-03-01 Compounds
PCT/EP2017/058049 WO2017174620A1 (en) 2016-04-07 2017-04-05 Benzo[b]furans as bromodomain inhibitors
KR1020187029128A KR20180132680A (en) 2016-04-07 2017-04-05 As the bromo domain inhibitor, benzo [b] furan
EP17715714.6A EP3440075B1 (en) 2016-04-07 2017-04-05 Benzo[b]furans as bromodomain inhibitors
RU2018133500A RU2018133500A (en) 2016-04-07 2017-04-05 Benzo [B] furans as bromodomain inhibitors
JP2018552148A JP6954920B2 (en) 2016-04-07 2017-04-05 Benzo [B] furan as a bromodomain inhibitor
CN201780020627.5A CN108884083B (en) 2016-04-07 2017-04-05 Benzo [ B ] furans as bromodomain inhibitors
CA3018275A CA3018275A1 (en) 2016-04-07 2017-04-05 Benzo[b]furans as bromodomain inhibitors
ES17715714T ES2785173T3 (en) 2016-04-07 2017-04-05 Benzo [b] furans as bromodomain inhibitors
US16/091,577 US10583112B2 (en) 2016-04-07 2017-04-05 Benzo[b]furans as bromodomain inhibitors
BR112018070514A BR112018070514A2 (en) 2016-04-07 2017-04-05 compound, pharmaceutical composition, combination, use of a compound or a pharmaceutically acceptable salt thereof, and method of treating a disease or condition
UY0001037191A UY37191A (en) 2016-04-07 2017-04-05 DIBENZOFURAN DERIVATIVES FOR USE AS BROMODOMINUM INHIBITORS
TW106111350A TW201802076A (en) 2016-04-07 2017-04-05 Compounds
AU2017245640A AU2017245640A1 (en) 2016-04-07 2017-04-05 Benzo[B]furans as bromodomain inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1703272.3A GB201703272D0 (en) 2017-03-01 2017-03-01 Compounds

Publications (1)

Publication Number Publication Date
GB201703272D0 true GB201703272D0 (en) 2017-04-12

Family

ID=58544267

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1703272.3A Ceased GB201703272D0 (en) 2016-04-07 2017-03-01 Compounds

Country Status (1)

Country Link
GB (1) GB201703272D0 (en)

Similar Documents

Publication Publication Date Title
GB201708456D0 (en) Senolytic compounds
GB201700814D0 (en) Compounds
GB201704327D0 (en) Compounds
GB201704325D0 (en) Compounds
GB201715342D0 (en) Compounds
GB201713962D0 (en) Compounds
GB201716871D0 (en) Compounds
GB201707938D0 (en) Compounds
GB201717051D0 (en) Compounds
GB201706162D0 (en) Compounds
GB201715786D0 (en) Compounds
GB201707856D0 (en) Compounds
GB201702221D0 (en) Compounds
GB201716369D0 (en) Compounds
GB201707852D0 (en) Compounds
GB201703282D0 (en) Compounds
GB201721326D0 (en) Compounds
GB201721330D0 (en) Compounds
GB201721331D0 (en) Compounds
GB201720495D0 (en) ß-lactone compounds
GB201720064D0 (en) Compounds
GB201719261D0 (en) Compounds
GB201717718D0 (en) Compounds
GB201717050D0 (en) Compounds
GB201716688D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)